Cerebras: Why I'm Selling The Biggest AI IPO Of The Year

Cerebras Systems surged 68% above its IPO offer price, but the stock is now facing significant volatility as the initial enthusiasm fades. The company is trading at extreme valuation multiples of 120x EV/Sales TTM and 202x P/E, with a bull case that still depends on underwriting a $510 million revenue target for 2025. That growth outlook is heavily concentrated in UAE-linked customers and supported by a $20 billion OpenAI commitment and an AWS partnership.

Analysis

The market is pricing CBRS as if its current revenue mix and customer concentration are already a durable platform economics story, but that is premature: this is still a capital-markets narrative, not an underwriting case. The immediate second-order winner is AMZN, not CBRS — AWS gets to “validate” the AI compute stack without bearing IPO valuation risk, while CBRS absorbs the burden of proving throughput, margins, and repeatability. If the next few quarters show any wobble in order timing or customer concentration, the stock can de-rate quickly because high-multiple IPOs usually trade on momentum until the first post-listing revisions force investors to re-anchor on path-to-profitability.

The biggest risk is not a fundamental collapse, but a sequencing problem: a few large deals can make FY25 look credible while masking how thin the recurring base really is. That creates a sharp air pocket over the next 1-2 quarters if the market realizes the 202x earnings multiple is backward-looking and highly sensitive to any change in gross margin or fulfillment assumptions. Conversely, any incremental disclosure on backlog conversion, multi-region AWS usage, or non-UAE customer diversification would be enough to stabilize the tape, because the short thesis needs one of those pillars to weaken to work.

The contrarian view is that the IPO pop may actually be underpriced optionality on AI infrastructure scarcity: if CBRS becomes the “picks-and-shovels” bottleneck for frontier model training, the market could tolerate absurd near-term multiples longer than skeptics expect. But that only holds if the company can show the revenue base is broadening faster than the bullish narrative is concentrating. In other words, the stock is less about valuation in isolation and more about whether the next print confirms it is a platform or just a very expensive one-cycle beneficiary.

Key Decisions for Investors

• Avoid chasing CBRS after the IPO pop; wait for the first post-listing earnings window or lockup-related weakness before considering entry. Risk/reward is poor until the company proves customer breadth and margin durability.
• For accounts allowed to express the AI infrastructure theme, use AMZN as the higher-quality beneficiary versus CBRS. AWS monetizes the upside with much lower single-name execution risk and a more defensible long-duration cash flow profile.
• If CBRS remains elevated into the next quarter, consider a tactical short against a basket of stronger AI infrastructure names only if borrow is workable; the setup is a momentum fade once the market shifts from narrative to revised guidance.
• Use call spreads rather than stock for any CBRS exposure: upside can persist on headline scarcity, but the implied volatility is likely to stay rich, making defined-risk options superior to outright longs.
• Set a catalyst watch on the next guidance update and customer-concentration disclosures; if no meaningful non-UAE diversification appears, treat any 20-30% rally from current levels as a sell-the-strength event.